|
|
 |
 |
HOME > ¿¬±¸°³¹ß > Product pipeline |
 |
|
| ºÐ ·ù |
ÇÁ·ÎÁ§Æ®¸í |
ÀûÀÀÁõ |
°³¹ß ´Ü°è |
ºñ°í |
| RS |
PC |
Phase |
RG |
M |
| P¥° |
P¥± |
P¥² |
|
| õ¿¬¹°ÀǾàǰ |
NRF803 |
³»ºÐºñ°è |
|
|
|
¡Ý |
|
|
|
|
| °³·®½Å¾à |
AGSCT |
½ÉÇ÷°ü°è |
|
|
|
|
|
|
¡Ý |
|
| AG1505 |
½ÉÇ÷°ü°è |
¡Ý |
|
|
|
|
|
|
|
| AG1604 |
ÁßÃ߽Űæ°è |
|
|
|
|
|
¡Ý |
|
|
| AG1605 |
È£Èí±â°è |
|
¡Ý |
|
|
|
|
|
|
| AG1703 |
¼Ò¿°ÁøÅëÁ¦ |
¡Ý |
|
|
|
|
|
|
|
| AG1704 |
ÁßÃ߽Űæ°è |
|
¡Ý |
|
|
|
|
|
|
| AG1705 |
½ÉÇ÷°ü°è |
|
|
¡Ý |
|
|
|
|
|
| AG1706 |
¼Òȱâ°è |
|
¡Ý |
|
|
|
|
|
|
| AG1801 |
È£Èí±â°è |
¡Ý |
|
|
|
|
|
|
|
| ½Å±ÔÁ¦Çü |
AG1601 |
±Ù°ñ°Ý°è |
|
|
¡Ý |
|
|
|
|
|
| ½Å¾à |
UAI-101 |
´ë»çÁúȯ°è |
|
¡Ý |
|
|
|
|
|
|
| ¹ÙÀÌ¿À½Å¾à |
AG-B1511 |
¸é¿ª°è |
|
¡Ý |
|
|
|
|
|
2021³â L/O |
| AG-B1512 |
³»ºÐºñ°è |
|
|
¡Ý |
|
|
|
|
2021³â L/O |
| AG-B1622 |
¸é¿ªÇ×¾ÏÁ¦ |
¡Ý |
|
|
|
|
|
|
|
| ü¿ÜÁø´Ü |
ü¿ÜÁø´Ü |
³¼Ò¾ÏÁ¶±âÁø´Ü |
¡Ý |
|
|
|
|
|
|
|
| M : Marketing |
RG : Registration |
Phase ¥² : Phase 3 Clinical Study |
Phase ¥± : Phase 2 Clinical Study |
| Phase ¥° : Phase 1 Clinical study |
PC : Pre-clinical Study |
RS : Research |
|
|
|
|
|